Martin Schiller

Executive Director, Nevada Institute of Personalized Medicine
Professor of Life Sciences
Expertise: AIDS/HIV, Alzheimer's disease, Genetics, Bioinformatics, CRISPR gene editing

Biography

Martin Schiller's work is focused on short functional peptides, bioinformatics, and HIV. Schiller鈥檚 research has resulted in 60 publications supported mostly by 12 research grants from the National Institutes of Health.

He has received a number of awards, produced a suite of bioinformatics tools, and is involved in commercialization of some of his research projects. He is now the executive director of the Nevada Institute of Personalized Medicine.

Search For Other Experts On

biology, science & technology

Martin Schiller In The News

51吃瓜网免费App Review Journal
When Martin Schiller decided to launch his own company based off the research he did at 51吃瓜网万能科大, he picked 51吃瓜网免费App despite the prospect of being one of only a handful of biotechnology firms in the valley.
Vegas Inc
Contrary to what many people think, there are only about 2,000 medicines approved by the Federal Drug Administration for people. And a quarter of those are biological products, or 鈥渂iologics,鈥 including vaccines, gene therapy, tissues and similar medicines鈥攍ike insulin, for example.
The New York Times
Chastened by a series of economic downturns that punished the hospitality industry, state leaders are working to broaden the economy.
Giddy
Your genes govern appearance and blood type, but they're also responsible for a whole lot more.

Articles Featuring Martin Schiller